We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+15.51%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.69B
AUM Growth
+$4.83B
Cap. Flow
+$4.16B
Cap. Flow %
42.97%
Top 10 Hldgs %
49.52%
Holding
195
New
84
Increased
29
Reduced
26
Closed
42

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$323M
2
BHC icon
Bausch Health
BHC
+$220M
3
HUM icon
Humana
HUM
+$172M
4
MRK icon
Merck
MRK
+$170M
5
ADBE icon
Adobe
ADBE
+$146M

Sector Composition

Rank Sector Weight
1 Healthcare 16.2%
2 Technology 10.56%
3 Energy 9.51%
4 Financials 7.85%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKRX
76
DELISTED
Akorn Inc
AKRX
$16.4M 0.17%
600,000
+100,000
+20% +$2.96M
PCRX icon
77
Pacira BioSciences
PCRX
$1.05B
$14M 0.14%
408,500
-191,500
-32% -$7.5M
META icon
78
Meta Platforms (Facebook)
META
$1.5T
$13.9M 0.14%
+108,200
New +$13.4M
CYH icon
79
Community Health Systems
CYH
$388M
$13.4M 0.14%
+1,161,200
New +$13.4M
BBAR icon
80
BBVA Argentina
BBAR
$3.82B
$13.3M 0.14%
670,483
-31,600
-5% -$636K
TGS icon
81
Transportadora de Gas del Sur
TGS
$4.47B
$12.1M 0.13%
1,843,552
AKS
82
DELISTED
AK Steel Holding Corp
AKS
$11.7M 0.12%
+2,426,500
New +$12.3M
MLM icon
83
Martin Marietta Materials
MLM
$34.4B
$9.78M 0.1%
+54,600
New +$10.4M
NKTR icon
84
Nektar Therapeutics
NKTR
$2.31B
$9.45M 0.1%
36,667
+23,334
+175% +$6.01M
LUV icon
85
Southwest Airlines
LUV
$21.9B
$9.11M 0.09%
234,300
+50,800
+28% +$1.93M
ABT icon
86
Abbott
ABT
$191B
$8.46M 0.09%
+200,000
New +$8.57M
KYNB
87
Kyntra Bio
KYNB
$28.2M
$8.28M 0.09%
16,000
+2,000
+14% +$942K
HRL icon
88
Hormel Foods
HRL
$14.3B
$8.15M 0.08%
+214,900
New +$7.98M
PR
89
Permian Resources
PR
$17.3B
$7.55M 0.08%
419,200
-495,800
-54% -$6.06M
ONCE
90
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$7.51M 0.08%
+125,000
New +$7.21M
ACIU icon
91
AC Immune
ACIU
$231M
$7M 0.07%
+425,000
New +$7.34M
NOC icon
92
Northrop Grumman
NOC
$77.1B
$6.97M 0.07%
+32,600
New +$7.06M
EXEL icon
93
Exelixis
EXEL
$14.1B
$6.39M 0.07%
+500,000
New +$5.41M
SIOX
94
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.3M 0.07%
+56,250
New +$6.75M
CHK
95
CALL
DELISTED
Chesapeake Energy Corporation
CHK
$6.27M 0.06%
+5,000
New +$5.77M
VFC icon
96
VF Corp
VFC
$5.92B
$5.94M 0.06%
+112,466
New +$6.49M
I
97
DELISTED
INTELSAT S. A.
I
$5.8M 0.06%
2,140,500
-91,600
-4% -$248K
RVNC
98
DELISTED
Revance Therapeutics, Inc.
RVNC
$5.27M 0.05%
325,000
+75,000
+30% +$1.09M
AAPL icon
99
Apple
AAPL
$4.99T
$5.01M 0.05%
+177,200
New +$4.69M
BHC icon
100
CALL
Bausch Health
BHC
$1.68B
$4.91M 0.05%
+200,000
New +$5.18M

Similar funds

PointState Capital's Q3 2016 Portfolio in Review

As of Q3 2016, PointState Capital held 195 positions worth $9.69B, up 100% from $4.85B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

PointState Capital deployed $4.16B of net new capital in Q3 2016, opening 84 new positions and adding to 29 existing holdings. Its largest new stake was Bank of America: 21,685,385 shares worth $339M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 27% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $309M trimmed.

  • PointState Capital's largest Q3 2016 buy was Bank of America: 21,685,385 shares worth $339M.
  • PointState Capital added most to Adobe in Q3 2016, an estimated $146M increase.
  • PointState Capital's biggest Q3 2016 reduction was Teva Pharmaceuticals, cutting an estimated $309M.
  • PointState Capital fully exited Allergan plc in Q3 2016, selling an estimated $163M.
  • PointState Capital's ten largest holdings make up 50% of its $9.69B portfolio in Q3 2016.
  • PointState Capital opened 84 new positions and closed 42 in Q3 2016.
  • PointState Capital's portfolio value rose 100% quarter-over-quarter to $9.69B.

Based on PointState Capital's 13F filing for Q3 2016, filed 14 Nov 2016.